Academic Journal
View in EDS

Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics

Bibliographic Details
Title: Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics
Authors: Balakumar Chandrasekaran, Muthupandian Saravanan
Source: Frontiers in Pharmacology, Vol 14 (2023)
Publisher Information: Frontiers Media S.A., 2023.
Publication Year: 2023
Collection: LCC:Therapeutics. Pharmacology
Subject Terms: COVID-19, kinase inhibitors, cancer, hepatocellular carcinoma, JAKs, FDA, Therapeutics. Pharmacology, RM1-950
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1663-9812
Relation: https://www.frontiersin.org/articles/10.3389/fphar.2023.1229673/full; https://doaj.org/toc/1663-9812
DOI: 10.3389/fphar.2023.1229673
Access URL: https://doaj.org/article/2e0fb99f80ae4127adb74e25b87740c0
Accession Number: edsdoj.2e0fb99f80ae4127adb74e25b87740c0
Database: Directory of Open Access Journals
FullText Text:
  Availability: 0
CustomLinks:
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=16639812&ISBN=&volume=14&issue=&date=20230601&spage=&pages=&title=Frontiers in Pharmacology&atitle=Editorial%3A%20Pharmacological%20and%20biochemical%20perspectives%20of%20kinase%20inhibitors%20in%20cancer%20and%20COVID-19%20therapeutics&aulast=Balakumar%20Chandrasekaran&id=DOI:10.3389/fphar.2023.1229673
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
  – Url: https://doaj.org/article/2e0fb99f80ae4127adb74e25b87740c0
    Name: EDS - DOAJ (s8985755)
    Category: fullText
    Text: View record from DOAJ
    MouseOverText: View record from DOAJ
Header DbId: edsdoj
DbLabel: Directory of Open Access Journals
An: edsdoj.2e0fb99f80ae4127adb74e25b87740c0
RelevancyScore: 967
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 967.342163085938
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Balakumar+Chandrasekaran%22">Balakumar Chandrasekaran</searchLink><br /><searchLink fieldCode="AR" term="%22Muthupandian+Saravanan%22">Muthupandian Saravanan</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: Frontiers in Pharmacology, Vol 14 (2023)
– Name: Publisher
  Label: Publisher Information
  Group: PubInfo
  Data: Frontiers Media S.A., 2023.
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2023
– Name: Subset
  Label: Collection
  Group: HoldingsInfo
  Data: LCC:Therapeutics. Pharmacology
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22COVID-19%22">COVID-19</searchLink><br /><searchLink fieldCode="DE" term="%22kinase+inhibitors%22">kinase inhibitors</searchLink><br /><searchLink fieldCode="DE" term="%22cancer%22">cancer</searchLink><br /><searchLink fieldCode="DE" term="%22hepatocellular+carcinoma%22">hepatocellular carcinoma</searchLink><br /><searchLink fieldCode="DE" term="%22JAKs%22">JAKs</searchLink><br /><searchLink fieldCode="DE" term="%22FDA%22">FDA</searchLink><br /><searchLink fieldCode="DE" term="%22Therapeutics%2E+Pharmacology%22">Therapeutics. Pharmacology</searchLink><br /><searchLink fieldCode="DE" term="%22RM1-950%22">RM1-950</searchLink>
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article
– Name: Format
  Label: File Description
  Group: SrcInfo
  Data: electronic resource
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: ISSN
  Label: ISSN
  Group: ISSN
  Data: 1663-9812
– Name: NoteTitleSource
  Label: Relation
  Group: SrcInfo
  Data: https://www.frontiersin.org/articles/10.3389/fphar.2023.1229673/full; https://doaj.org/toc/1663-9812
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.3389/fphar.2023.1229673
– Name: URL
  Label: Access URL
  Group: URL
  Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/2e0fb99f80ae4127adb74e25b87740c0" linkWindow="_blank">https://doaj.org/article/2e0fb99f80ae4127adb74e25b87740c0</link>
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsdoj.2e0fb99f80ae4127adb74e25b87740c0
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.2e0fb99f80ae4127adb74e25b87740c0
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2023.1229673
    Languages:
      – Text: English
    Subjects:
      – SubjectFull: COVID-19
        Type: general
      – SubjectFull: kinase inhibitors
        Type: general
      – SubjectFull: cancer
        Type: general
      – SubjectFull: hepatocellular carcinoma
        Type: general
      – SubjectFull: JAKs
        Type: general
      – SubjectFull: FDA
        Type: general
      – SubjectFull: Therapeutics. Pharmacology
        Type: general
      – SubjectFull: RM1-950
        Type: general
    Titles:
      – TitleFull: Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Balakumar Chandrasekaran
      – PersonEntity:
          Name:
            NameFull: Muthupandian Saravanan
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 16639812
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Frontiers in Pharmacology
              Type: main
ResultId 1